Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer gene therapy: developments to 2000.

A R Bateman1, K J Harrington, A A Melcher

  • 1Molecular Medicine Program, Mayo Foundation, Rochester, MN 55905, USA. bateman.andrew@mayo.edu

Expert Opinion on Investigational Drugs
|November 28, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting Regulatory T Cells for Cancer Immunotherapy: Promises and Pitfalls.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Spaceflight-Associated Neuro-Ocular Syndrome and Idiopathic Intracranial Hypertension: Can Anemia and Hyperemia Underlie Both?

AJNR. American journal of neuroradiology·2024
Same author

Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040): Subgroup analysis by pattern of disease recurrence.

Oral oncology·2023
Same author

OX40 and 4-1BB delineate distinct immune profiles in sarcoma.

Oncoimmunology·2022
Same author

Looking a Gift Horse in the Mouth: Observations on NHS England's Interim Guidance on Pembrolizumab in Head and Neck Squamous Cell Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2020
Same author

Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma.

Clinical and experimental immunology·2019

Gene therapy offers innovative cancer treatment by targeting molecular mechanisms. This review explores current advancements and challenges in gene therapy to overcome obstacles for wider clinical use.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biotechnology

Background:

  • Cancer research is deepening molecular understanding, revealing new therapeutic targets.
  • Gene therapy presents a promising strategy for innovative cancer treatment.
  • Despite progress, significant barriers hinder widespread clinical application of gene therapy.

Purpose of the Study:

  • To review current directions in cancer gene therapy.
  • To highlight novel developments aimed at overcoming existing challenges.
  • To provide an overview of the field for researchers and clinicians.

Main Methods:

  • Literature review of recent gene therapy clinical trials and research.
  • Analysis of identified obstacles in cancer gene therapy.

Related Experiment Videos

  • Synthesis of emerging strategies and technological advancements.

    • Main Results:

    • Progress in understanding cancer at the molecular level.
    • Identification of persistent barriers in gene therapy delivery and efficacy.
    • Emergence of novel approaches to enhance gene therapy effectiveness.

    Conclusions:

    • Continued molecular insights are crucial for advancing cancer gene therapy.
    • Overcoming current obstacles is key to realizing the full potential of gene therapy.
    • Novel developments show promise for future clinical success in cancer treatment.